Ramipril Dosage and Treatment Protocol for Hypertension and Heart Failure
For patients with hypertension and heart failure, ramipril should be initiated at 1.25-2.5 mg daily for hypertension and 2.5 mg twice daily for heart failure post-MI, with gradual titration to target doses of 2.5-5 mg twice daily for heart failure and 2.5-20 mg daily for hypertension. 1, 2
Initial Dosing
For Hypertension:
- Starting dose: 2.5 mg once daily (1.25 mg if patient has volume depletion, is on diuretics, or has renal impairment) 1
- Maintenance dose: 2.5-20 mg daily (single dose or divided twice daily) 1
- If blood pressure is not controlled with ramipril alone, add a diuretic 1
For Heart Failure Post-MI:
- Starting dose: 2.5 mg twice daily (5 mg total daily) 1, 2
- If hypotension occurs at this dose, reduce to 1.25 mg twice daily 1
- Target dose: 5 mg twice daily 2, 1
Titration Protocol
Initial phase:
Titration phase:
Monitoring schedule:
- 1-2 weeks after each dose increase
- At 3 months after reaching maintenance dose
- Every 6 months thereafter 3
Special Considerations
Renal Impairment:
- For hypertension with renal impairment: Start with 1.25 mg once daily, maximum 5 mg daily 1
- For heart failure with renal impairment: Start with 1.25 mg once daily, maximum 2.5 mg twice daily 1
- Avoid thiazide diuretics if GFR <30 mL/min 2, 3
Concomitant Medications:
- Diuretics: Loop diuretics preferred for heart failure; consider temporary reduction when initiating ramipril 2, 3
- Avoid potassium-sparing diuretics during initiation of therapy 2
- Avoid NSAIDs and COX-2 inhibitors 2, 3
Combination Therapy
For Hypertension:
- If blood pressure not controlled with ramipril alone, add a thiazide diuretic 1, 2
- For patients with CAD and hypertension, consider beta-blockers in combination with ramipril 2
For Heart Failure:
- Combine with beta-blockers and mineralocorticoid receptor antagonists 2
- Loop diuretics should be used for symptomatic relief of fluid overload 2
- Target blood pressure <130/80 mmHg (<140/80 in elderly patients) 2
Common Pitfalls and Caveats
Hypotension risk:
- Higher risk with initial dose, especially in volume-depleted patients
- Consider evening administration to minimize blood pressure drop, though evidence for this in heart failure is limited 2
- If severe hypotension occurs, place patient supine and consider IV fluids
Renal function deterioration:
- Small increases in creatinine are expected and usually not concerning
- Discontinue if renal function deteriorates substantially 2
Hyperkalemia:
- Avoid combination with potassium supplements or potassium-sparing diuretics 1
- Monitor potassium levels closely, especially when combining with aldosterone antagonists
Underdosing:
Contraindications:
- Bilateral renal artery stenosis
- Previous angioedema with ACE inhibitor therapy 2
Ramipril is an effective ACE inhibitor for both hypertension and heart failure, with proven mortality benefits when dosed appropriately. Careful titration and monitoring are essential to achieve optimal outcomes while minimizing adverse effects.